Edition:
United Kingdom

Nightstar Therapeutics PLC (NITE.OQ)

NITE.OQ on NASDAQ Stock Exchange Global Select Market

13.41USD
4:50pm GMT
Change (% chg)

$0.26 (+1.98%)
Prev Close
$13.15
Open
$13.20
Day's High
$13.60
Day's Low
$12.29
Volume
6,944
Avg. Vol
7,546
52-wk High
$24.70
52-wk Low
$10.10

Chart for

About

Nightstar Therapeutics PLC, formerly Nightstar Therapeutics Limited, is a clinical-stage gene therapy company. The Company is focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness. The Company is developing a... (more)

Overall

Beta: --
Market Cap(Mil.): $470.69
Shares Outstanding(Mil.): 28.10
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Nightstar Therapeutics announces pricing of initial public offering

* Pricing initial public offering of 5.4 million American Depositary Shares at $14 per ADS for total gross proceeds of about $75 million Source text for Eikon: Further company coverage:

28 Sep 2017

Earnings vs. Estimates